Related Experiment Video
Updated: Jun 27, 2026
10:02
A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
Published on: November 3, 2016
Perrault Syndrome with progressive nervous system involvement.
Carsten Kobe1, Lutz W Kracht, Lars Timmermann
1Department of Nuclear Medicine, University of Cologne, Cologne, Germany. carsten.kobe@uk-koeln.de
Clinical Nuclear Medicine
|November 27, 2008
Summary
Perrault Syndrome (PS) can cause progressive ataxia and cerebral leucodystrophy. Fluorodeoxyglucose positron emission tomography (PET) aids in early detection of central nervous system involvement in PS patients.
Area of Science:
- Neurology
- Genetics
- Radiology
Background:
- Perrault Syndrome (PS) is characterized by gonadal dysgenesis and sensorineural deafness in females.
- Neurologic manifestations in PS are increasingly recognized, prompting investigation into their association with the syndrome.
Observation:
- A 21-year-old female with Perrault Syndrome presented with progressive ataxia.
- Magnetic resonance imaging revealed high intensity signals in the cerebral white matter, suggestive of leucodystrophy.
- Fluorodeoxyglucose positron emission tomography (PET) indicated progressive heredoataxia.
Findings:
- The patient's presentation and imaging findings are consistent with the spectrum of neurologic symptoms in Perrault Syndrome.
- Cerebral leucodystrophy is a potential neurological manifestation within Perrault Syndrome.
- PET imaging demonstrated progressive heredoataxia, highlighting the central nervous system involvement.
Implications:
- PET imaging may serve as a valuable tool for early detection and monitoring of central nervous system involvement in Perrault Syndrome.
- Understanding the neurological spectrum of PS is crucial for comprehensive patient management.
- Further research is warranted to elucidate the mechanisms underlying the neurological aspects of Perrault Syndrome.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:28Disorders of the Nervous Tissue
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.